{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T22:30:24Z","timestamp":1786487424212,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc. Diabetol. \u2013 Endocrinol. Rep."],"DOI":"10.1186\/s40842-026-00329-w","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T22:02:39Z","timestamp":1786485759000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic signatures and machine learning identify gut-liver-heart axis dysfunction as a potential link to major adverse cardiovascular events in coronary artery disease"],"prefix":"10.1186","volume":"12","author":[{"given":"Min-Qing","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ka","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka-Wing","family":"Au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe Yu-Yan","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee-Man","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song-Yan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen Siu-Ling","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Fat","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"issue":"9","key":"329_CR1","doi-asserted-by":"publisher","first-page":"e275","DOI":"10.1161\/CIR.0000000000001412","volume":"153","author":"LP Palaniappan","year":"2026","unstructured":"Palaniappan LP, Allen NB, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. 2026 heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation. 2026;153(9):e275\u2013906. https:\/\/doi.org\/10.1161\/CIR.0000000000001412.","journal-title":"Circulation"},{"key":"329_CR2","doi-asserted-by":"publisher","first-page":"100742","DOI":"10.1016\/j.lanwpc.2023.100742","volume":"35","author":"SS Kasim","year":"2023","unstructured":"Kasim SS, Ibrahim N, Malek S, Ibrahim KS, Aziz MF, Song C, et al. Validation of the general framingham risk score (FRS), SCORE2, revised PCE and WHO CVD risk scores in an Asian population. Lancet Reg Health West Pac. 2023;35:100742. https:\/\/doi.org\/10.1016\/j.lanwpc.2023.100742.","journal-title":"Lancet Reg Health West Pac"},{"issue":"5","key":"329_CR3","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.2337\/dc06-1358","volume":"30","author":"RL Coleman","year":"2007","unstructured":"Coleman RL, Stevens RJ, Retnakaran R, Holman RR. Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes. Diabetes Care. 2007;30(5):1292\u201393. https:\/\/doi.org\/10.2337\/dc06-1358.","journal-title":"Diabetes Care"},{"issue":"14","key":"329_CR4","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.jacc.2022.07.026","volume":"80","author":"M Sud","year":"2022","unstructured":"Sud M, Sivaswamy A, Chu A, Austin PC, Anderson TJ, Naimark DMJ, et al. Population-based recalibration of the framingham risk score and pooled cohort equations. J Am Coll Cardiol. 2022;80(14):1330\u201342. https:\/\/doi.org\/10.1016\/j.jacc.2022.07.026.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"329_CR5","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.jacc.2025.08.047","volume":"87","author":"GA Mensah","year":"2026","unstructured":"Mensah GA, Arnold N, Prabhu SD, Ridker PM, Welty FK. Inflammation and cardiovascular disease: 2025 ACC scientific statement: a report of the American College of Cardiology. J Am Coll Cardiol. 2026;87(11):1381\u2013404. https:\/\/doi.org\/10.1016\/j.jacc.2025.08.047.","journal-title":"J Am Coll Cardiol"},{"key":"329_CR6","doi-asserted-by":"publisher","first-page":"692893","DOI":"10.3389\/fendo.2021.692893","volume":"12","author":"Z Jing","year":"2021","unstructured":"Jing Z, Liu L, Shi Y, Du Q, Zhang D, Zuo L, et al. Association of coronary artery disease and metabolic syndrome: usefulness of serum metabolomics approach. Front Endocrinol (Lausanne). 2021;12:692893. https:\/\/doi.org\/10.3389\/fendo.2021.692893.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"329_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41392-024-01811-6","volume":"9","author":"JS Fleishman","year":"2024","unstructured":"Fleishman JS, Kumar S. Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets. Signal Transduct Target Ther. 2024;9(1):97. https:\/\/doi.org\/10.1038\/s41392-024-01811-6.","journal-title":"Signal Transduct Target Ther"},{"issue":"16","key":"329_CR8","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1016\/j.jacc.2019.03.024","volume":"73","author":"WHW Tang","year":"2019","unstructured":"Tang WHW, Backhed F, Landmesser U, Hazen SL. Intestinal microbiota in cardiovascular health and disease: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73(16):2089\u2013105. https:\/\/doi.org\/10.1016\/j.jacc.2019.03.024.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"329_CR9","doi-asserted-by":"publisher","first-page":"101309","DOI":"10.1016\/j.jacbts.2025.05.004","volume":"10","author":"A Hakeem","year":"2025","unstructured":"Hakeem A, van Berlo J, Revelo XS. The cardiohepatic axis in metabolic disease: liver to heart. JACC Basic Transl Sci. 2025;10(7):101309. https:\/\/doi.org\/10.1016\/j.jacbts.2025.05.004.","journal-title":"JACC Basic Transl Sci"},{"issue":"1","key":"329_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","volume":"24","author":"A Wahlstrom","year":"2016","unstructured":"Wahlstrom A, Sayin SI, Marschall HU, Backhed F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 2016;24(1):41\u201350. https:\/\/doi.org\/10.1016\/j.cmet.2016.05.005.","journal-title":"Cell Metab"},{"issue":"8","key":"329_CR11","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.metabol.2016.05.003","volume":"65","author":"N Katsiki","year":"2016","unstructured":"Katsiki N, Mikhailidis DP, Mantzoros CS. Non-alcoholic fatty liver disease and dyslipidemia: an update. Metabolism. 2016;65(8):1109\u201323. https:\/\/doi.org\/10.1016\/j.metabol.2016.05.003.","journal-title":"Metabolism"},{"issue":"1","key":"329_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12933-025-02711-x","volume":"24","author":"XR Zhang","year":"2025","unstructured":"Zhang XR, Zhong WF, Liu RY, Huang JL, Fu JX, Gao J, et al. Improved prediction and risk stratification of major adverse cardiovascular events using an explainable machine learning approach combining plasma biomarkers and traditional risk factors. Cardiovasc Diabetol. 2025;24(1):153. https:\/\/doi.org\/10.1186\/s12933-025-02711-x.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"329_CR13","doi-asserted-by":"publisher","first-page":"10206","DOI":"10.1038\/ncomms10206","volume":"6","author":"CS Tang","year":"2015","unstructured":"Tang CS, Zhang H, Cheung CYY, Xu M, Ho JCY, Zhou W, et al. Exome-wide association analysis reveals novel coding sequence variants associated with lipid traits in Chinese. Nat Commun. 2015;6(1):10206. https:\/\/doi.org\/10.1038\/ncomms10206.","journal-title":"Nat Commun"},{"issue":"9596","key":"329_CR14","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453\u201357. https:\/\/doi.org\/10.1016\/S0140-6736(07)61602-X.","journal-title":"Lancet"},{"issue":"7","key":"329_CR15","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/nprot.2011.335","volume":"6","author":"WB Dunn","year":"2011","unstructured":"Dunn WB, Broadhurst D, Begley P, Zelena E, Francis-McIntyre S, Anderson N, et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc. 2011;6(7):1060\u201383. https:\/\/doi.org\/10.1038\/nprot.2011.335.","journal-title":"Nat Protoc"},{"issue":"6","key":"329_CR16","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1161\/ATVBAHA.121.317513","volume":"42","author":"C-CF Tam","year":"2022","unstructured":"Tam C-CF, Chan YH, Wong YK, Li Z, Zhu X, Su KJ, et al. Multi-omics signatures link to ticagrelor effects on vascular function in patients with acute coronary syndrome. Arterioscler Thromb Vasc Biol. 2022;42(6):789\u201398. https:\/\/doi.org\/10.1161\/ATVBAHA.121.317513.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"W1","key":"329_CR17","doi-asserted-by":"publisher","first-page":"W388","DOI":"10.1093\/nar\/gkab382","volume":"49","author":"Z Pang","year":"2021","unstructured":"Pang Z, Chong J, Zhou G, de Lima Morais DA, Chang L, Barrette M, et al. MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res. 2021;49(W1):W388\u201396. https:\/\/doi.org\/10.1093\/nar\/gkab382.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"329_CR18","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.2337\/dc12-1766","volume":"36","author":"Q Fang","year":"2013","unstructured":"Fang Q, Li H, Song Q, Yang W, Hou X, Ma X, et al. Serum fibroblast growth factor 19 levels are decreased in Chinese subjects with impaired fasting glucose and inversely associated with fasting plasma glucose levels. Diabetes Care. 2013;36(9):2810\u201314. https:\/\/doi.org\/10.2337\/dc12-1766.","journal-title":"Diabetes Care"},{"key":"329_CR19","doi-asserted-by":"publisher","first-page":"1728865","DOI":"10.3389\/fnut.2025.1728865","volume":"12","author":"L Berkowitz","year":"2026","unstructured":"Berkowitz L, Araneda P, Cofre G, Sara D, Olsen M, Urzua I, et al. The controversial role of linoleic acid in cardiometabolic health: from molecular pathways to human studies. Front Nutr. 2026;12:1728865. https:\/\/doi.org\/10.3389\/fnut.2025.1728865.","journal-title":"Front Nutr"},{"key":"329_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.atherosclerosis.2019.11.018","volume":"292","author":"F Marangoni","year":"2020","unstructured":"Marangoni F, Agostoni C, Borghi C, Catapano AL, Cena H, Ghiselli A, et al. Dietary linoleic acid and human health: focus on cardiovascular and cardiometabolic effects. Atherosclerosis. 2020;292:90\u201398. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.11.018.","journal-title":"Atherosclerosis"},{"issue":"2","key":"329_CR21","doi-asserted-by":"publisher","first-page":"e000898","DOI":"10.1136\/openhrt-2018-000898","volume":"5","author":"JJ DiNicolantonio","year":"2018","unstructured":"DiNicolantonio JJ, O\u2019Keefe JH. Omega-6 vegetable oils as a driver of coronary heart disease: the oxidized linoleic acid hypothesis. Open Heart. 2018;5(2):e000898. https:\/\/doi.org\/10.1136\/openhrt-2018-000898.","journal-title":"Open Heart"},{"issue":"2","key":"329_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/2042018810375656","volume":"1","author":"V Vangaveti","year":"2010","unstructured":"Vangaveti V, Baune BT, Kennedy RL. Review: hydroxyoctadecadienoic acids: novel regulators of macrophage differentiation and atherogenesis. Ther Adv Endocrinol Metab. 2010;1(2):51\u201360. https:\/\/doi.org\/10.1177\/2042018810375656.","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"12","key":"329_CR23","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41569-021-00569-6","volume":"18","author":"D Montaigne","year":"2021","unstructured":"Montaigne D, Butruille L, Staels B. PPAR control of metabolism and cardiovascular functions. Nat Rev Cardiol. 2021;18(12):809\u201323. https:\/\/doi.org\/10.1038\/s41569-021-00569-6.","journal-title":"Nat Rev Cardiol"},{"key":"329_CR24","doi-asserted-by":"publisher","first-page":"1667037","DOI":"10.3389\/fendo.2025.1667037","volume":"16","author":"Z Li","year":"2025","unstructured":"Li Z, Chu H, Yang L. White adipose tissue browning and peroxisome proliferator activated receptors in MASLD. Front Endocrinol (Lausanne). 2025;16:1667037. https:\/\/doi.org\/10.3389\/fendo.2025.1667037.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9493","key":"329_CR25","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","volume":"366","author":"JA Dormandy","year":"2005","unstructured":"Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive study (PROspective pioglitAzone clinical trial in macroVascular events): a randomised controlled trial. Lancet. 2005;366(9493):1279\u201389. https:\/\/doi.org\/10.1016\/S0140-6736(05)67528-9.","journal-title":"Lancet"},{"issue":"4","key":"329_CR26","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1161\/CIRCRESAHA.120.316242","volume":"127","author":"M Witkowski","year":"2020","unstructured":"Witkowski M, Weeks TL, Hazen SL. Gut microbiota and cardiovascular disease. Circ Res. 2020;127(4):553\u201370. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.316242.","journal-title":"Circ Res"},{"issue":"10","key":"329_CR27","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1161\/ATVBAHA.118.311726","volume":"38","author":"YK Wong","year":"2018","unstructured":"Wong YK, Cheung CYY, Tang CS, Au KW, Hai JSH, Lee CH, et al. Age-biomarkers-clinical risk factors for prediction of cardiovascular events in patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2018;38(10):2519\u201327. https:\/\/doi.org\/10.1161\/ATVBAHA.118.311726.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"329_CR28","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3389\/fendo.2020.00282","volume":"11","author":"J Hu","year":"2020","unstructured":"Hu J, Liu Z, Tong Y, Mei Z, Xu A, Zhou P, et al. Fibroblast growth factor 19 levels predict subclinical atherosclerosis in men with type 2 diabetes. Front Endocrinol (Lausanne). 2020;11:282. https:\/\/doi.org\/10.3389\/fendo.2020.00282.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"329_CR29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/nu11010171","volume":"11","author":"DF Romagnolo","year":"2019","unstructured":"Romagnolo DF, Donovan MG, Doetschman TC, Selmin OI. N-6 linoleic acid induces epigenetics alterations associated with colonic inflammation and cancer. Nutrients. 2019;11(1):171. https:\/\/doi.org\/10.3390\/nu11010171.","journal-title":"Nutrients"},{"issue":"3","key":"329_CR30","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.livres.2021.02.002","volume":"5","author":"S Maliha","year":"2021","unstructured":"Maliha S, Guo GL. Farnesoid X receptor and fibroblast growth factor 15\/19 as pharmacological targets. Liver Res. 2021;5(3):142\u201350. https:\/\/doi.org\/10.1016\/j.livres.2021.02.002.","journal-title":"Liver Res"},{"issue":"2","key":"329_CR31","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1194\/jlr.M027094","volume":"54","author":"X Wu","year":"2013","unstructured":"Wu X, Ge H, Baribault H, Gupte J, Weiszmann J, Lemon B, et al. Dual actions of fibroblast growth factor 19 on lipid metabolism. J Lipid Res. 2013;54(2):325\u201332. https:\/\/doi.org\/10.1194\/jlr.M027094.","journal-title":"J Lipid Res"},{"issue":"3","key":"329_CR32","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1097\/HEP.0000000000000607","volume":"79","author":"ME Rinella","year":"2024","unstructured":"Rinella ME, Lieu HD, Kowdley KV, Goodman ZD, Alkhouri N, Lawitz E, et al. A randomized, double-blind, placebo-controlled trial of aldafermin in patients with NASH and compensated cirrhosis. Hepatology. 2024;79(3):674\u201389. https:\/\/doi.org\/10.1097\/HEP.0000000000000607.","journal-title":"Hepatology"}],"container-title":["Cardiovascular Diabetology \u2013 Endocrinology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40842-026-00329-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40842-026-00329-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40842-026-00329-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T22:02:39Z","timestamp":1786485759000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40842-026-00329-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["329"],"URL":"https:\/\/doi.org\/10.1186\/s40842-026-00329-w","relation":{},"ISSN":["3059-4057"],"issn-type":[{"value":"3059-4057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"assertion":[{"value":"1 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Review Board of the University of Hong Kong\/Hospital Authority Hong Kong West Cluster. Written informed consent was obtained from all participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"56"}}